Skip to main content
. 2021 Jun 28;15:2815–2830. doi: 10.2147/DDDT.S281639

Figure 2.

Figure 2

(A) Intracellular activation pathway for nitroimidazoles. (B) Keto mycolic acid synthesis pathway. Pretomanid blocks formation of keto mycolic acids, a component of the cell wall, by impairing oxidation of precursor, hydroxymycolic acid.